ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019
Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?
Shilpa R Jain et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.